Valuation: Chugai Pharmaceutical Co., Ltd.

Market Cap 12,399B 76.71B 67.38B 62.08B 58.04B 109B 7,238B 111B 745B 288B 3,568B 288B 282B P/E 2026 *
24.4x
P/E 2027 * 20.9x
Enterprise Value 11,477B 71B 62.37B 57.46B 53.73B 101B 6,699B 103B 689B 267B 3,302B 267B 261B EV / Sales 2026 *
8.27x
EV / Sales 2027 * 7.32x
Free-Float
38.12%
Yield 2026 *
1.81%
Yield 2027 * 2.08%
1 day-1.33%
1 week-1.54%
Current month-5.80%
1 month-2.00%
3 months-12.03%
6 months-11.61%
Current year-9.81%
1 week 7,434
Extreme 7434
7,596
1 month 7,270
Extreme 7270
7,964
Current year 7,270
Extreme 7270
10,700
1 year 5,942
Extreme 5942
10,700
3 years 3,767
Extreme 3767
10,700
5 years 3,191
Extreme 3191
10,700
10 years 1,003.33
Extreme 1003.3333
10,700
Manager TitleAgeSince
Chief Executive Officer 63 2021-02-28
Director of Finance/CFO 59 2024-03-27
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 63 2020-02-29
Director/Board Member 59 2024-03-27
Director/Board Member 51 2025-02-28
Change 5-day change 1-year change 3-year change Capi.($)
-1.33%-1.54%-1.96%+77.00% 76.71B
+0.93%+2.65%+42.33%+145.77% 1,006B
+1.61%+7.22%+60.81%+47.98% 589B
+3.51%+12.31%+31.15%+78.88% 430B
-0.61%+5.11%+29.26%+21.27% 331B
-0.50%+6.90%+37.22%+23.11% 288B
-0.29%+6.74%+32.63%+38.93% 285B
-1.60%+12.69%-27.48%-42.00% 213B
+0.40%+4.51%+25.85%+55.35% 190B
-1.05%+0.06%+16.91%+59.86% 154B
Average +0.11%+5.32%+24.67%+50.62% 356.25B
Weighted average by Cap. +0.68%+5.25%+34.53%+70.25%

Financials

2026 *2027 *
Net sales 1,387B 8.58B 7.54B 6.94B 6.49B 12.18B 810B 12.4B 83.32B 32.27B 399B 32.22B 31.52B 1,535B 9.5B 8.34B 7.69B 7.19B 13.48B 896B 13.73B 92.21B 35.72B 442B 35.66B 34.88B
Net income 509B 3.15B 2.76B 2.55B 2.38B 4.47B 297B 4.55B 30.56B 11.84B 146B 11.82B 11.56B 593B 3.67B 3.22B 2.97B 2.78B 5.21B 346B 5.3B 35.63B 13.8B 171B 13.78B 13.48B
Net Debt -923B -5.71B -5.01B -4.62B -4.32B -8.1B -539B -8.25B -55.42B -21.47B -265B -21.43B -20.96B -1,166B -7.21B -6.33B -5.84B -5.46B -10.23B -680B -10.42B -70.02B -27.12B -335B -27.08B -26.49B
Logo Chugai Pharmaceutical Co., Ltd.
Chugai Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research, development, manufacture, sale, import and export of pharmaceutical products. The pharmaceutical products and medical devices for patients include ACTEMRA, Avastin, ALAGLIO, Aresensa, Kadosaira, Gazaiba, Seruseputo, Zeruborafu, Zeroda, Taruseba, Tecentoriku, Pajeta and other products. The products are mainly applied to the treatment of cancer, kidney diseases, kidney transplantation, bone and joint diseases such as rheumatoid arthritis, osteoporosis, knee osteoarthritis and locomotive syndrome, influenza, hemophilia and other diseases. The Company is also engaged in the provision of management services, transportation and storage services, as well as drug information literature research services. The Company operates within the domestic market and to overseas markets, including Switzerland, United Kingdom, Germany, France, China, Singapore, Korea and the United States.
Employees
5,104
Date Price Change Volume
26-06-26 JP¥7,434.00 -1.33% 2,058,200
26-06-25 JP¥7,534.00 +0.45% 1,882,900
26-06-24 JP¥7,500.00 +0.89% 1,977,300
26-06-23 JP¥7,434.00 -1.17% 2,411,300
26-06-22 JP¥7,522.00 -0.37% 1,238,100
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
7,534.00JPY
Average target price
9,973.33JPY
Spread / Average Target
+32.38%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4519 Stock